Literature DB >> 29411949

Discrimination of malignant and normal kidney tissue with short wave infrared dispersive Raman spectroscopy.

Miki Haifler1,2, Isaac Pence3, Yu Sun2, Alexander Kutikov1, Robert G Uzzo1, Anita Mahadevan-Jansen3, Chetan A Patil2.   

Abstract

Renal mass biopsy is still controversial due to imperfect accuracy. Raman spectroscopy (RS) demonstrated promise as an in vivo real-time, nondestructive diagnostic tool in many malignancies. Short wave infrared (SWIR) RS has the potential to improve on previous RS systems for renal mass diagnosis. The aim of this study is to evaluate a SWIR RS system in differentiating normal and malignant renal samples. Measurements were acquired using a benchtop RS system with excitation wavelength at 1064 nm and an InGaAs array detector. Processed spectra were classified with a Bayesian machine learning algorithm, sparse multinomial logistic regression. Sensitivity and receiver operating characteristic curve analyses evaluated the classifier accuracy. Accuracy of the classifier was 92.5% with sensitivity and specificity of 95.8% and 88.8%, respectively. For posterior probability of malignant class assignment, the area under the ROC curve is 0.94 (95% confidence interval: 0.89-0.99, P < .001). SWIR RS accurately differentiated normal and malignant kidney tumors. RS has the potential to be used as a diagnostic tool in kidney cancer.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Raman spectroscopy; biopsy; renal cell carcinoma; tissue diagnosis

Mesh:

Year:  2018        PMID: 29411949     DOI: 10.1002/jbio.201700188

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  8 in total

1.  [Application of Raman-based technologies in the detection of urological tumors].

Authors:  Z Hao; S H Yue; L Q Zhou
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

Review 2.  Artificial Intelligence and Its Impact on Urological Diseases and Management: A Comprehensive Review of the Literature.

Authors:  B M Zeeshan Hameed; Aiswarya V L S Dhavileswarapu; Syed Zahid Raza; Hadis Karimi; Harneet Singh Khanuja; Dasharathraj K Shetty; Sufyan Ibrahim; Milap J Shah; Nithesh Naik; Rahul Paul; Bhavan Prasad Rai; Bhaskar K Somani
Journal:  J Clin Med       Date:  2021-04-26       Impact factor: 4.241

Review 3.  Machine learning in the optimization of robotics in the operative field.

Authors:  Runzhuo Ma; Erik B Vanstrum; Ryan Lee; Jian Chen; Andrew J Hung
Journal:  Curr Opin Urol       Date:  2020-11       Impact factor: 2.808

4.  Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.

Authors:  Janina Müller-Deile; George Sarau; Ahmed M Kotb; Christian Jaremenko; Ulrike E Rolle-Kampczyk; Christoph Daniel; Stefan Kalkhof; Silke H Christiansen; Mario Schiffer
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

Review 5.  Artificial intelligence for renal cancer: From imaging to histology and beyond.

Authors:  Karl-Friedrich Kowalewski; Luisa Egen; Chanel E Fischetti; Stefano Puliatti; Gomez Rivas Juan; Mark Taratkin; Rivero Belenchon Ines; Marie Angela Sidoti Abate; Julia Mühlbauer; Frederik Wessels; Enrico Checcucci; Giovanni Cacciamani
Journal:  Asian J Urol       Date:  2022-06-18

6.  Model-based characterization platform of fiber optic extended-wavelength diffuse reflectance spectroscopy for identification of neurovascular bundles.

Authors:  Yu Sun; Alexander P Dumont; Mohammed Shahriar Arefin; Chetan A Patil
Journal:  J Biomed Opt       Date:  2022-09       Impact factor: 3.758

7.  Efficacy of raman spectroscopy in the diagnosis of kidney cancer: A systematic review and meta-analysis.

Authors:  Hongyu Jin; Xiao He; Hui Zhou; Man Zhang; Qingqing Tang; Lede Lin; Jianqi Hao; Rui Zeng
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

Review 8.  The complementary value of intraoperative fluorescence imaging and Raman spectroscopy for cancer surgery: combining the incompatibles.

Authors:  L J Lauwerends; H Abbasi; T C Bakker Schut; P B A A Van Driel; J A U Hardillo; I P Santos; E M Barroso; S Koljenović; A L Vahrmeijer; R J Baatenburg de Jong; G J Puppels; S Keereweer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-01       Impact factor: 10.057

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.